Emerald Mutual Fund Advisers Trust Adamas Pharmaceuticals, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

$1.45 Billion
Q4 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Jan 29, 2021	SELL	N/A	-307,723 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	N/A	-314,326 Reduced 50.53%	307,723 $1.27 Million
Q2 2020 Jul 28, 2020	BUY	N/A	25,000 Added 4.19%	622,049 $1.59 Million
Q1 2020 Apr 30, 2020	BUY	N/A	40,022 Added 7.18%	597,049 $1.73 Million
Q4 2019 Jan 29, 2020	SELL	N/A	-51,992 Reduced 8.54%	557,027 $2.11 Million
Q3 2019 Oct 31, 2019	SELL	N/A	-7,645 Reduced 1.24%	609,019 $3.12 Million
Q2 2019 Jul 31, 2019	BUY	N/A	51,345 Added 9.08%	616,664 $3.82 Million
Q4 2018 Jan 31, 2019	SELL	N/A	-61,422 Reduced 9.8%	565,319 $4.83 Million
Q3 2018 Oct 31, 2018	BUY	N/A	76,387 Added 13.88%	626,741 $12.5 Million
Q2 2018 Jul 31, 2018	BUY	N/A	17,877 Added 3.36%	550,354 $14.2 Million
Q1 2018 Apr 26, 2018	BUY	N/A	2,540 Added 0.48%	532,477 $12.7 Million
Q3 2017 Oct 30, 2017	BUY	N/A	529,937	529,937 $11.2 Million

About Adamas Pharmaceuticals, Inc.

Ticker ADMS
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,408,100
Market Cap $376M

More about ADMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.